Products
-
- BBB DamageCell Death and ApoptosisNeuroinflammationNeuronal Damage and RepairOxidative StressVascular Mechanisms
- 3D BBB Models
- Organ-on-a-Chip BBB ModelsTranswell Models3D BBB Models Culture Substrate
- 3D HydrogelsCollagensAnmial BBB ModelsCell Lines for BBB Modeling
- Immortalized CellsPrimary CellsStem Cells
Recombinant Human Gastrin Releasing Peptide Protein (Fc Tag) (AC1179)
Cat.#: ACPP-1179
Specifications
Despition Recombinant Human Gastrin Releasing Peptide Protein (Fc Tag) for SDS-PAGE SIZE 50 µg Source Recombinant Protein Length Fragment Expression System HEK293 cells Protein Species Human Sequence GRP (Val24-Met50) + hFc (Glu99-Ala330) Molecular Weight 29.0 kDa without signal peptide Purity > 95% by SDS-PAGE and Coomassie blue staining. Form Lyophilized Tag C-terminal Human Fc Tag Applications SDS-PAGE Storage Lyophilized was stored at -20°C to -80°C, while reconstituted was aliquot and stored at -80°C. Avoid freeze/thaw cycles. Shipping Shipped at 4°C Citation Guidance If you use our product in a scientific publication, please cite it as "Ace Therapeutics Cat.#". Click here to submit your paper's PubMed ID (PMID) to receive rewards. Related Products
Cat.# Name Size Price ACPP-1013 Recombinant Human GPCR GPRC5B Protein (Fc Tag) (AC1013) 50 µg inquiry ACPP-1800 Human RCN3 Protein (AC1800) 5 µg inquiry ACPP-1126 Recombinant Human Peripherin Protein (AC1126) 25 µl inquiry ACPP-1757 Human Artemin Protein (AC1757) 5 µg inquiry ACPP-1841 Human DDAH1 Protein (AC1841) 5 µg inquiry ACPP-1624 Human EFNA1 Protein (AC1624) 5 µg inquiry ACPP-1123 Recombinant Rat GFAP Protein (AC1123) 25 µl inquiry ACPP-1079 Dopamine Receptor D1 Blocking Peptide (AC1079) 250 µg inquiry ACPP-1295 Human ASPH Protein (AC1295) 5 µg inquiry ACPP-1199 Beta crystallin S Blocking Peptide (AC1199) 250 µg inquiry All of our products are intended for preclinical research use only and cannot be used to diagnose, treat or manage patients.
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.
0Inquiry Basket